federal_register: 2010-207
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2010-207 | Implantation or Injectable Dosage Form New Animal Drugs; Hyaluronate Sodium | Rule | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Anika Therapeutics, Inc. The supplemental NADA provides for a revised human food safety warning for use of hyaluronate sodium injectable solution in horses. | 2010-01-11 | 2010 | 1 | https://www.federalregister.gov/documents/2010/01/11/2010-207/implantation-or-injectable-dosage-form-new-animal-drugs-hyaluronate-sodium | https://www.govinfo.gov/content/pkg/FR-2010-01-11/pdf/2010-207.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Anika Therapeutics, Inc. The supplemental NADA provides for a revised human food safety... |